Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Rigel Pharmaceuticals Inc (RIGL)

148 + Investors. Track Smart Money conviction in RIGL. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↓ -37
Streak
1Q ▼
Buyers last Q
46%

Smart Money Signals — RIGL

Based on 148 hedge funds · latest filing: 2026 Q1 · updated quarterly

📉

Selling streak — 1 quarter in a row

last 6Q
For 1 consecutive quarter, more hedge funds reduced or closed their RIGL positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.
📊

High ownership — 80% of 3.0Y peak

80% of all-time peak
148 funds currently hold this stock — 80% of the 3.0-year high of 185 funds (reached 2025 Q4). Ownership is elevated but not yet at maximum concentration. Room to grow, but watch if the trend reverses.
🚀

Fast accumulation — +24% more funds vs a year ago

fund count last 6Q
+29 new funds entered over the past year (+24% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟠

More sellers than buyers — 46% buying

83 buying96 selling
Last quarter: 96 funds reduced or exited vs 83 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.
⚠️

Fewer new buyers each quarter (-32 vs last Q)

new funds entering per quarter
Funds opening this position for the first time: 20 → 49 → 46 → 14. Each quarter fewer new institutions are entering. This usually means most funds that wanted in are already in — the stock is well-known but the pool of potential new buyers is shrinking.
🔄

Mostly new holders — 29% entered in last year

■ 5% conviction (2yr+) ■ 66% medium ■ 29% new
Only 7 funds (5%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.
💎

Buying through price weakness — shares -2%, value -43%

Value
-43%
Shares
-2%
Last quarter: funds added -2% more shares while total portfolio value only changed -43%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.
➡️

Steady discovery — ~14 new funds/quarter

25 → 20 → 49 → 46 → 14 new funds/Q
New funds entering each quarter: 20 → 49 → 46 → 14. Consistent flow of new institutional buyers without clear acceleration or slowdown.
📊

Mixed cohorts — 5% veterans, 40% new entrants

■ 5% veterans ■ 55% 1-2yr ■ 40% new
Of 153 current holders: 8 (5%) held 2+ years, 84 held 1–2 years, 61 (40%) entered in the past year. Balanced distribution — some institutional memory, some recent momentum buyers.
🏆

Elite ownership — 52% AUM from top-100 funds

52% from top-100 AUM funds
43 of 148 holders are among the 100 largest funds by AUM, controlling 52% of total institutional value in RIGL. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.
3.4
out of 10
Low Exit Risk
Exit risk score 3.4/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — RIGL

In 2026 Q1, 83 hedge funds were net buyers of RIGL (14 opened a new position, 69 added to an existing one), while 96 reduced or exited (45 trimmed, 51 sold completely) — a 46% buyer ratio, indicating roughly balanced activity. 52% of total institutional value in RIGL is held by top-100 AUM funds, reflecting elite-tier ownership quality. Net fund flow last quarter: -37 funds (more exits than new entries). Total institutional holders: 148.

Hedge Fund Ownership: RIGL

How many hedge funds hold RIGL — quarterly history vs. share price
Quarterly hedge fund ownership of RIGL vs. share price

Market Analysis: RIGL

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: RIGL

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Rigel Pharmaceuticals Inc (RIGL) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much RIGL has moved relative to its sector benchmark (XLV) since the 2026 Q2 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End June 30, 2026 · 47d ago
RIGL
+8.8%
XLV
+5.5%

RIGL outperformed XLV by +3.3% since June 30, 2026.

Since 13F Filing Date August 14, 2026 · 2d ago
RIGL
+0.0%
XLV
+0.0%

Since the filing became public, RIGL outperformed XLV by +0.0% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

18 top-rated funds 1 high-conviction
Consensus
5.6
/ 10
breadth
×
Elite
1.8
/ 10
conviction
Hedge Fund Positioning: RIGL
2026 Q2 Stats Unlock in 3 days 148 + Investors

Track Smart Money conviction in RIGL. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 148 185 -20.0%
13F Shares 16M 16M -2.02%
Total Value $396M $695M -43.06%
New Positions 14 46 -32
Increased Positions 66 66 -
Closed Positions 51 24 +27
Reduced Positions 45 59 -14
Total Calls 3 3 -
Total Puts 2 3 -33.33%
PUT/CALL Ratio 0.67 1.0 Bullish

Statistics: RIGL

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q2)

148 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in RIGL. Verified SEC 13F-HR filings.

QUARTER:
2026 Q2 filings are still coming in. Only funds that have filed so far are shown — top holders may not have reported yet. Full 13F data typically settles by ~50 days after quarter-end.
Top 25 RIGL holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 CM Management, LLC 6.21% 250,000 $9.8M
2 Soleus Capital Management, L.P. 2.49% 1,843,504 $72.1M
3 Lionhunter Capital Management, LLC 1.11% 63,045 $2.5M
4 Armistice Capital, LLC 0.80% 1,672,000 $65.4M
5 Globeflex Capital L P 0.56% 112,672 $4.4M
6 Virtus Investment Advisers, LLC 0.32% 35,400 $1.4M
7 CenterBook Partners LP 0.21% 109,575 $4.3M
8 Sierra Summit Advisors LLC 0.14% 31,876 $1.2M
9 Diadema Partners LP 0.11% 22,816 $893K
10 Hennion & Walsh Asset Management, Inc. 0.10% 87,844 $3.4M
11 Bridgeway Capital Management, LLC 0.09% 124,184 $4.9M
12 Persistent Asset Partners Ltd 0.07% 5,821 $228K
13 NJ State Employees Deferred Compensation Plan 0.06% 20,000 $567K
14 Burney Co/ 0.06% 55,769 $2.2M
15 Ritholtz Wealth Management 0.06% 94,450 $3.7M
16 Pale Fire Capital SE 0.04% 14,252 $558K
17 O'shaughnessy Asset Management, LLC 0.02% 131,177 $5.1M
18 Aquatic Capital Management LLC 0.02% 17,233 $674K
19 Segall Bryant & Hamill, LLC 0.02% 45,878 $1.8M
20 Truvestments Capital LLC 0.01% 2,387 $93K
21 American Century Companies Inc 0.01% 741,718 $29.0M
22 OMERS ADMINISTRATION Corp 0.01% 51,900 $2.0M
23 Engineers Gate Manager LP 0.01% 23,866 $934K
24 Nomura Asset Management International INC. 0.01% 195,000 $7.6M
25 Marshall Wace, LLP 0.01% 367,393 $14.4M
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Rigel Pharmaceuticals Inc (RIGL)

What does the Smart Money Trend signal show for RIGL?

Selling streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds reduced or closed their RIGL positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.

What is the institutional breadth score for RIGL?

More sellers than buyers — 46% buying: Last quarter: 96 funds reduced or exited vs 83 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.

What is the fund quality score for RIGL holders?

Elite ownership — 52% AUM from top-100 funds: 43 of 148 holders are among the 100 largest funds by AUM, controlling 52% of total institutional value in RIGL. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held RIGL?

Mostly new holders — 29% entered in last year: Only 7 funds (5%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.

Is it too late to buy Rigel Pharmaceuticals Inc (RIGL) following the 2026 Q2 hedge fund 13F filings?

As of today, RIGL has moved +0.0% since the 2026 Q2 13F filing date (August 14, 2026), compared to +0.0% for the XLV sector ETF — an outperformance of +0.0%. Since the quarter end (June 30, 2026), RIGL has gained +8.8% vs +5.5% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →